These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36512131)

  • 1. States of Uncertainty, Risk-Benefit Assessment and Early Clinical Research: A Conceptual Investigation.
    Schnarr A; Mertz M
    Sci Eng Ethics; 2022 Dec; 28(6):68. PubMed ID: 36512131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the need for restricting the probabilistic analysis in risk assessments to variability.
    Aven T
    Risk Anal; 2010 Mar; 30(3):354-60; author reply 381-4. PubMed ID: 19919552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A suggestion for the quantification of precise and bounded probability to quantify epistemic uncertainty in scientific assessments.
    Raices Cruz I; Troffaes MCM; Sahlin U
    Risk Anal; 2022 Feb; 42(2):239-253. PubMed ID: 35007348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conceptual, methodological, and ethical problems in communicating uncertainty in clinical evidence.
    Han PK
    Med Care Res Rev; 2013 Feb; 70(1 Suppl):14S-36S. PubMed ID: 23132891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "This Is What We Don't Know": Treating Epistemic Uncertainty in Bayesian Networks for Risk Assessment.
    Sahlin U; Helle I; Perepolkin D
    Integr Environ Assess Manag; 2021 Jan; 17(1):221-232. PubMed ID: 33151017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probability and possibility-based representations of uncertainty in fault tree analysis.
    Flage R; Baraldi P; Zio E; Aven T
    Risk Anal; 2013 Jan; 33(1):121-33. PubMed ID: 22831561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Irrelevance of the Risk-Uncertainty Distinction.
    Roser D
    Sci Eng Ethics; 2017 Oct; 23(5):1387-1407. PubMed ID: 28597223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.
    Ritter L; Solomon K; Sibley P; Hall K; Keen P; Mattu G; Linton B
    J Toxicol Environ Health A; 2002 Jan; 65(1):1-142. PubMed ID: 11809004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined Monte Carlo and possibilistic approach to uncertainty propagation in event tree analysis.
    Baraldi P; Zio E
    Risk Anal; 2008 Oct; 28(5):1309-26. PubMed ID: 18631304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epistemic uncertainty in the ranking and categorization of probabilistic safety assessment model elements: issues and findings.
    Borgonovo E
    Risk Anal; 2008 Aug; 28(4):983-1001. PubMed ID: 18554270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communicating Uncertainty in Benefits and Harms: A Review of Patient Decision Support Interventions.
    Bansback N; Bell M; Spooner L; Pompeo A; Han PKJ; Harrison M
    Patient; 2017 Jun; 10(3):311-319. PubMed ID: 27905072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to risk evaluation and management: risk-based, precaution-based, and discourse-based strategies.
    Klinke A; Renn O
    Risk Anal; 2002 Dec; 22(6):1071-94. PubMed ID: 12530780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the Characterization of Epistemic Uncertainties in PM2.5 Risk Analyses.
    Smith AE; Gans W
    Risk Anal; 2015 Mar; 35(3):361-78. PubMed ID: 24941886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two approaches to incorporate clinical data uncertainty into multiple criteria decision analysis for benefit-risk assessment of medicinal products.
    Wen S; Zhang L; Yang B
    Value Health; 2014 Jul; 17(5):619-28. PubMed ID: 25128056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal assessment of pharmaceutical treatments: why standards of evidence should not be the same for benefits and harms?
    Osimani B; Mignini F
    Drug Saf; 2015 Jan; 38(1):1-11. PubMed ID: 25519721
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.